Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis (Q39138238)

9 September 2017

title

Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis (English)

1 reference

9 September 2017

0 references

0 references

Yoshihiro Kamada

1

1 reference

9 September 2017

Hideki Fujii

2

1 reference

9 September 2017

Hironobu Fujii

3

1 reference

9 September 2017

Yoshiyuki Sawai

4

1 reference

9 September 2017

Yoshinori Doi

5

1 reference

9 September 2017

Naofumi Uozumi

6

1 reference

9 September 2017

Kayo Mizutani

7

1 reference

9 September 2017

Maaya Akita

8

1 reference

9 September 2017

Motoya Sato

9

1 reference

9 September 2017

Sachiho Kida

10

1 reference

9 September 2017

Noriaki Kinoshita

11

1 reference

9 September 2017

Nobuhiro Maruyama

12

1 reference

9 September 2017

Takayuki Yakushijin

13

1 reference

9 September 2017

Masanori Miyazaki

14

1 reference

9 September 2017

Hisao Ezaki

15

1 reference

9 September 2017

Naoki Hiramatsu

16

1 reference

9 September 2017

Yuichi Yoshida

17

1 reference

9 September 2017

Shinichi Kiso

18

1 reference

9 September 2017

Yasuharu Imai

19

1 reference

9 September 2017

Norifumi Kawada

20

1 reference

9 September 2017

Tetsuo Takehara

21

1 reference

9 September 2017

Eiji Miyoshi

22

1 reference

9 September 2017

publication date

17 September 2013

1 reference

Proteomics - Clinical Applications

9 September 2017

published in

1 reference

9 September 2017

volume

7

1 reference

9 September 2017

issue

9-10

1 reference

9 September 2017

page(s)

648-656

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Glycosylation in cellular mechanisms of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Biological function of fucosylation in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Histopathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Cholangiocyte injury and ductopenic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

90K (Mac-2 BP) and galectins in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Galectin-3 stimulates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Galectin-3 induces endothelial cell morphogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

The HCV serum proteome: a search for fibrosis protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200137

21 January 2018

Identifiers

DOI

10.1002/PRCA.201200137

1 reference

9 September 2017

1 reference